ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0527

Gaps In Documentation Of Psoriatic Arthritis Domains In General Rheumatologic Practices Compared To Rheumatology-Dermatology Combined Clinics

Alexandra Lauren Rice1, Sarah Hopkins Gillespie2, Nikhil Sai3, Soumya Reddy1, Joseph Merola4, Rebecca Haberman5, Alexis Ogdie6 and Jose Scher7, 1NYU Grossman School of Medicine, New York, NY, 2University of Pennsylvania, Philadelphia, PA, 3University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 4UT Southwestern Medical Center, Dallas, TX, 5NYU Langone Health, New York, NY, 6Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Wilmington, DE, 7New York University School of Medicine, New York, NY

Meeting: ACR Convergence 2025

Keywords: informatics, Musculoskeletal Examination, physical examination, Psoriatic arthritis, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0522–0553) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: To apply current treatment recommendations for psoriatic arthritis (PsA), clinicians must perform a comprehensive assessment of psoriatic disease domains, including a musculoskeletal exam (tender and swollen joints, dactylitis, enthesitis, axial disease) and a skin and nail exam for psoriasis (PsO). Documentation in the electronic medical record (EMR) serves as a proxy for these assessments. Additionally, ICD coding of psoriatic disease influences administrative database research. This study aimed to compare documentation of psoriatic domains and ICD coding practices between PsA specialist providers and general rheumatologists at two academic centers.

Methods: We identified patients with ICD-coded diagnoses of PsA who were seen by either general rheumatologists or PsA combined-clinic specialist providers at two established PPACMAN (Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network) sites. Clinical notes were reviewed for documentation of musculoskeletal and cutaneous PsA domains. We also evaluated the accuracy and completeness of ICD coding for PsA and/or PsO to assess the reliability of EMR-derived discrete data. Fisher’s exact tests were used to assess relationships between provider type, documentation practices, and ICD coding.

Results: Across multiple academic centers, PsA combined-clinic specialist providers documented psoriatic disease domains significantly more consistently than general rheumatologists. Musculoskeletal domains—including tender and swollen joint counts (p< 0.001), assessment of spondyloarthritis (p=0.017), dactylitis (p< 0.001), and enthesitis (p< 0.001)—were more routinely documented by PsA specialists. Cutaneous domains were also more consistently documented by specialists, including PsO location (p< 0.001), phenotypic subset (p< 0.001), and use of standardized psoriasis assessment tools such as BSA, PGA, and PASI scores (p< 0.001). Furthermore, PsA specialists more frequently applied appropriate ICD codes for PsO (p< 0.001) and for both PsA and PsO (p< 0.001).

Conclusion: In this multicenter retrospective study, PsA specialist providers more thoroughly documented musculoskeletal and cutaneous disease domains and more accurately coded for PsA and PsO compared to generalists. These findings highlight gaps in documentation among general rheumatologists and underscore the need for enhanced training in psoriatic disease assessment. Despite significant efforts from multiple organizations, patient advocacy foundations and academics to increase awareness, improvement in both assessment and documentation are still needed. Improved documentation tools may facilitate both better clinical evaluation and more reliable research using EHR or claims-based data.

Supporting image 1Table 1: Demographics for NYU, Penn, and Combined Patient Populations, grouped by provider type and institution

Supporting image 2Table 2: Documentation of Psoriatic Disease Domains, grouped by provider type and institution

Supporting image 3Table 3: Documentation of ICD Coded Diagnoses, grouped by provider type and institution


Disclosures: A. Rice: None; S. Hopkins Gillespie: None; N. Sai: None; S. Reddy: Bristol-Myers Squibb(BMS), 1, Janssen, 1, 5, UCB, 1; J. Merola: AbbVie/Abbott, 2, 12, Investigator, Amgen, 2, 12, Investigator, Arena, 2, Avotres, 2, Biogen, 2, 12, Investigator, Bristol-Myers Squibb(BMS), 2, 12, Investigator, Celgene, 2, Dermavant, 2, 12, Investigator, Eli Lilly, 2, 12, Investigator, EMD Serono, 2, Janssen, 2, 12, Investigator, Leo Pharma, 2, 12, Investigator, Merck/MSD, 2, Novartis, 2, 12, Investigator, Pfizer, 2, 12, Investigator, Regeneron, 2, 12, Investigator, Sanofi, 2, 12, Investigator, Sun Pharma, 2, 12, Investigator, UCB, 2, 12, Investigator; R. Haberman: Johnson and Johnson, 1, 5, Novartis, 1; A. Ogdie: AbbVie, 5, Amgen, 5, 11, Bristol Myers Squibb, 5, Celgene, 5, CorEvitas, 2, Eli Lilly, 5, Novartis, 5, 11, Pfizer, 5, 11; J. Scher: Bristol-Myers Squibb(BMS), 2, Johnson & Johnson, 2, 5, Novartis, 2, Pfizer, 2, 5, UCB, 2.

To cite this abstract in AMA style:

Rice A, Hopkins Gillespie S, Sai N, Reddy S, Merola J, Haberman R, Ogdie A, Scher J. Gaps In Documentation Of Psoriatic Arthritis Domains In General Rheumatologic Practices Compared To Rheumatology-Dermatology Combined Clinics [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/gaps-in-documentation-of-psoriatic-arthritis-domains-in-general-rheumatologic-practices-compared-to-rheumatology-dermatology-combined-clinics/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gaps-in-documentation-of-psoriatic-arthritis-domains-in-general-rheumatologic-practices-compared-to-rheumatology-dermatology-combined-clinics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology